Translation regulatory long non‐coding RNA 1 negatively regulates cell radiosensitivity via the miR‐22‐3p/SP1 axis in non‐small cell lung cancer

Author:

Zhong Ming1,Fang Zheng1,Guo Weixi1,Yu Xiuyi1ORCID

Affiliation:

1. Department of Thoracic Surgery The First Affiliated Hospital of Xiamen University Xiamen China

Abstract

AbstractObjectiveNon‐small cell lung cancer (NSCLC) occupies 85% of lung cancer. Long non‐coding RNAs (LncRNAs) can regulate the radiosensitivity of cancers. This study explored the mechanism of lncRNA TRERNA1 in the radiosensitivity of NSCLC cells.MethodsLncRNA TRERNA1 level in NSCLC cell lines was determined. NSCLC cell radiation tolerance was measured. TRERNA1 expression was silenced or overexpressed in A549/HCC827 cells with the highest/lowest radiation tolerance, respectively. The contents of γ‐H2AX and SA‐β‐gal in NSCLC cells after radiation induction were detected. The targeted binding of TRERNA1 to miR‐22‐3p and miR‐22‐3p to SP1 were verified by dual‐luciferase assay. SP1 expression were detected. Functional rescue experiments were implemented to confirm the roles of miR‐22‐3p and SP1 in the regulatory mechanism of TRERNA1.ResultsTRERNA1 was upregulated in NSCLC cells. TRERNA1 silencing enhanced radiosensitivity of NSCLC cells. TRERNA1 silencing elevated the contents of γ‐H2AX and SA‐β‐gal in A549 cells after radiation induction, while TRERNA1 overexpression showed an opposite trend in HCC827 cells. There were targeting relationships between TRERNA1 and miR‐22‐3p, and miR‐22‐3p and SP1. miR‐22‐3p repression or SP1 overexpression abolished the effects of TRERNA1 silencing.ConclusionTRERNA1 silencing enhanced radiosensitivity of NSCLC cells via the miR‐22‐3p/SP1 axis. This study may offer new targets for NSCLC treatment.

Publisher

Wiley

Subject

Genetics (clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3